Chemistry: analytical and immunological testing – Involving production or treatment of antibody
Reexamination Certificate
2006-10-10
2006-10-10
Harris, Alana M. (Department: 1643)
Chemistry: analytical and immunological testing
Involving production or treatment of antibody
C436S086000, C436S512000, C436S536000, C424S093700, C424S093710, C424S184100, C424S193100, C424S277100, C424S200100, C424S200100, C530S388800, C530S388850, C530S380000, C530S385000, C530S386000, C530S387100, C530S388150, C530S388220
Reexamination Certificate
active
07118924
ABSTRACT:
An improved method for producing human antibodies in SCID mice is provided. The improvement includes the use of dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents.
REFERENCES:
patent: 5663481 (1997-09-01), Gallinger et al.
patent: 5672480 (1997-09-01), Dowell et al.
patent: 5681729 (1997-10-01), Kudo et al.
patent: 6432653 (2002-08-01), Okarma
patent: 6497876 (2002-12-01), Maraskovsky
Stein, S.H. et al, Eur. J. Immunol. 20: 403-407, 1990.
Kunkl, A. et al., Immunology 43: 371- 1981.
Tjoa, B. et al, The Prostate, 28: 65-69, 1996.
Yoshida, K. et al, Immunology, 84: 117-126, 1995.
Yoshida, K. et al. Eur. J. Immunol. 24: 464-468, 1994.
Cella et al., “Ligation of CD40 on Dendritic Cells Triggers Production of High Levels of Interleukin-12 and Enhances T Cell Stimulatory . . . ”, J. Exp. Med., vol. 184 Aug. 1996 pp. 747-752.
Couglan et al., “Enhanced Proliferation of CD4+ T Cells Induced by Dendritic Cells Following Antigen Uptake in the Presence of . . . ”, Vet. Immunology and Immunopathology, vol. 49 (1996) pp. 321-330.
Garner et al., “Low Expression of CD20 and CD23 in Epstein-Barr Virus-Induced B-Cell Tumors in SCID/hu Mice”, American Jour. of Pathology, vol. 142, No. 2 (Feb. 1993) pp. 353-358.
Grossman et al., “Antitumor Responses Induced by Transgenic Expression of CD40 Ligand”, Human Gene Therapy 8:1935-1943 (Nov. 1997).
Heufler et al., “Interleukin-12 is Produced by Dendritic Cells and Mediates T-Helper 1 Development as well as Interferon-y Production by T Helper 1 Cells” Eur. J. Immuno. (1996) 26:659-668.
Kato et al., “Gene Transfer of CD40-Ligand Induces Autologous Immune Recognition of Chronic Lymphocytic Leukemia B Cells”, J. Clin. Invest., vol. 101, No. 5 (Mar. 1998) pp. 1133-1141.
Nishioka et al., “The Role of CD40-CD40 Ligand Interaction in Human T Cell-B Cell Collaboration” Amer. Assoc. of Immunologists, (1994) pp. 1027-1036.
Tjoa et al., “Presentation of Prostate Tumor Antigens by Dendritic Cells Stimulates T-Cell Proliferation and Cytotoxicity”, The Prostate 28:65-69 (1996).
Koch et al., Brief Definitive Report “High Level IL-12Production of Murine Dendritic Cells: Upregulation via MHC Class II and . . . ”, Depts.of Dermatology, Univs. of Innsbruck, Wurzburg and Erlagene-Nurnberg Rec'd for publicaton Mar. 1996; revised Jun. 1996; pp. 741-746.
Marco A. Coccia et al., “High Titer, Prostate Specific Antigen-Specific Human IgG Production by hu-PBL-SCID Mice Immunized with Antigen-Mouse IgG2a Complex-Pulsed Autologous Dendritic Cells,” The Journal of Immunology, The American Assocation of Immunologists, p. 5772-5780, 1998.
Tary-Lehmann et al., J. Exp. Med., 1992, 175(2):503-516 (full text).
Somasundarum et al., Clin. Exp. Immunol., 1995, 101:94-99 (full text).
Martino et al., Eur. J. Immunol., 1993, 23(5):1023-1028 (full text).
Cella et al. (1997) Origin, maturation and antigen presenting function of dendritic cells.Curr. Opin. Immunol., 9(1):10-16.
Peters et al. (1996) Dendritic cells: from ontogenic orphans to myelomonocytic descendants.Immunology Today17(6):273-282.
Romani et al. (1994) Proliferating dendritic cell precursors in human blood.J. Exp. Med.180:83-93.
Caux et al. (1995) Human dendritic Langerhans cells generated in vitro frim CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen.J. Immunol.155:5427-5435.
Santiago-Schwartz et al. (1995) Stem cell factor enhances dendritic cell development,Dendritic Cells in Fundamental and Clinical Immunology, vol. 2, Ed. by J. Bancherau et al., Plenum Press, NY, 1995.
Linsley et al. (1991) Binding of the B cell activation antigen B7.1 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.J. Exp. Med.173(3):721-730.
Caux et al. (1994) B70/B7.2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.J. Exp. Med.180(5): 1841-1847.
Bakker et al. (1995) Generation of cytotoxic T lymphocytes from healthly donors after presentation of melanoma-associated antigen derived epitopes by dendritic cells in vitro.Cancer Res.55:5330-5334.
Van Elsas et al. (1996) Peptide pulsed dendritic cells induce tumorcidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.Eur. J. Immunol.26: 1683-1689.
Fanger et al. (1996) Type 1 (CD64) and type II (CD32) FcyR receptor-mediated phagocytosis by human blood dendritic cells.J. Immunol.157:541-548.
Fanger et al. (1997) Characterization of expression, cytokine regulation and effector function of the high affinity receptor FcyRI (CD64) expressed on human blood dendritic cells.J. Immunol.158: 3090-3098.
Gosselin et al. (1992) Enhanced antigen presentation using Fc gamma receptor (monocyte-macrophage)-specific immunogens.J. Immunol.149(11): 3477-3481.
Sallusto et al. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha.J. Exp. Med.179: 1109-1118.
Sornasse et al. (1992) Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.J. Exp. Med.175: 15-21.
Grouard et al. (1995) Human follicular dendritic cells enhance cytokine dependent growth and differentiation of CD40-activated B cells.J. Immunol.155: 3345-3352.
Clark et al. (1992) Cultured humna follicular dendritic cells: growth characteristics and interactions with B cells.J. Immunol.148(11):3327-3335.
Bosma, M.J., and Carroll, A.M. (1991) The SCID mouse mutant: Definition, characterization and potential uses.Annu. Rev. Immunol.9: 323-350.
Mosier, D.E. (1991) Adoptive transfer of human lymphoid cells to severely immunodeficient mice, models for normal human immune function, autoimmunity, lymphomagenesis and AIDS.Adv. Immunol.50: 303-325.
Walker et al. (1994) The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice.Immunology83(2): 163-170.
Uchibayasi et al. (1995) A human monoclonal antibody to a human self-antigen, CD2 derived from human peripheral blood lymphocytes engrafted in SCID mice.Hybridoma14(4): 313-321.
Challita-Eid et al. (1998) A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway.J. Immunol.160(7): 3419-3426.
Garcia et al. (1997) Limits of the Human-PBL-SCID Mice Model; Severe Restriction of the Vβ T-Cell Repertoire of Engrafted Human T Cells.Blood89(1): 329-336.
Brams Peter
Coccia Marco Anthony
Biogen IDEC Inc.
Harris Alana M.
Pillsbury Winthrop Shaw & Pittman LLP
LandOfFree
Method for producing human antibodies in SCID mice which... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing human antibodies in SCID mice which..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing human antibodies in SCID mice which... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3686326